Dimeloom
A digital-health evidence workflow linking current program authority, credential criteria, technical test results, privacy and security review, corrections, submission and agency response.
Digital-health companies pursuing a Medicare-facing app listing may need to coordinate credential evidence, interoperability tests, identity controls, privacy and security material and submission status across several owners. The supplied research confirms a February announcement selecting one credential for entry, a free hosted interoperability-test substrate and no reviewed specialist workflow SaaS. It does not establish the complete current program contract from primary agency sources.
The input's July 4, 2026 deadline is already elapsed. Its descriptions also alternate between one selected credential and a dual-path workflow. Before building, Dimeloom must verify the current listing program, governing agency materials, accepted credential paths, technical requirements, submission channel, dates and transition rules. Historical urgency cannot be copied into a live checklist.
The product would preserve authority source, effective date, criterion, owner, evidence item, document version, test profile, test request, observed result, discrepancy, remediation, retest, reviewer finding, credential submission, provider acknowledgment, issued credential, listing submission, agency acknowledgment, correction and final response. Passing an automated interoperability test does not prove clinical safety, privacy, security, accessibility, identity assurance, legal compliance or program acceptance.
The pilot should use synthetic data and exclude protected health information and production credentials. Qualified privacy, security, clinical, accessibility and legal owners retain their decisions. The workflow must not claim that evidence is sufficient, that a credential will issue or that an agency will list the product. The buyer hypothesis is a compliance, interoperability, security, product or market-access leader at a digital-health company seeking the current pathway; company band, product type, data flows, current stage, budget and external advisers require validation.
A compliance, interoperability, security, product or market-access leader at a digital-health company pursuing the current Medicare-facing app-listing pathway.
The 2026 program signal was timely when captured, but the stated deadline has elapsed and current status must replace it.
Versioned criteria, evidence workflows and test orchestration can scale through software across applicants.
The supplied record has several cross-references but no inbound or grounded cross-vertical convergence.
The input identifies a focused digital-health workflow, confirms one credential announcement and a free technical-test substrate, and reports no direct specialist SaaS.
The supplied deadline is elapsed, current primary agency authority is missing, the credential-path description conflicts and technical evidence cannot establish broader readiness.
Discussion
No comments yet — be the first to weigh in.